Fund Holdings — GREAT POINT PARTNERS LLC

Total Portfolio Value:
$424.45M
Total Bought:
$153.83M
Total Sold:
$159.64M
Net Transaction:
-$5.81M
Notable People:
Ronald Marc Panzier
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Vor Biopharma Inc.(VOR)1,750,0001,700,000-50,000$31.22M$31.30M7.37%+$77.0K
ABIVAX Société AnonymeADS(ABVX)0204,314+204,314$0$27.23M6.41%+$27.23M
Vera Therapeutics, Inc.CL A(VERA)199,348600,836+401,488$8.02M$25.78M6.07%+$17.76M
Zura Bio LimitedCL A(ZURA)4,215,9304,215,9300$25.08M$24.87M5.86%-$210.8K
Alumis Inc856,061856,0610$18.86M$24.09M5.68%+$5.23M
Sol-Gel Technologies LtdSHS NEW
SHS NEW
274,363274,3630$21.74M$20.34M4.79%-$1.39M
Definium Therapeutics, Inc.(DFTX)0425,000+425,000$0$19.99M4.71%+$19.99M
Annexon, Inc.(ANNX)2,500,0003,500,000+1,000,000$13.85M$19.98M4.71%+$6.13M
Oruka Therapeutics, Inc.(ORKA)183,330183,3300$8.99M$17.45M4.11%+$8.46M
MoonLake ImmunotherapeuticsCL A(MLTX)500,000855,813+355,813$9.32M$16.66M3.93%+$7.34M
Sagimet Biosciences Inc.COM SER A(SGMT)02,029,933+2,029,933$0$15.69M3.70%+$15.69M
Contineum Therapeutics, Inc.CL A(CTNM)800,198921,481+121,283$10.45M$15.10M3.56%+$4.65M
Immix Biopharma, Inc.(IMMX)350,0001,277,642+927,642$3.19M$13.17M3.10%+$9.98M
Climb Bio, Inc.(CLYM)1,334,1301,000,000-334,130$9.14M$13.04M3.07%+$3.90M
Amylyx Pharmaceuticals, Inc.(AMLX)1,750,000700,000-1,050,000$24.32M$12.57M2.96%-$11.75M
Nektar Therapeutics(NKTR)316,453175,000-141,453$22.77M$12.22M2.88%-$10.55M
Neurogene Inc.(NGNE)500,000352,180-147,820$10.08M$11.08M2.61%+$996.1K
LB Pharmaceuticals Inc(LBRX)300,000317,221+17,221$7.40M$10.30M2.43%+$2.90M
Opus Genetics, Inc.(IRD)324,3401,970,187+1,645,847$1.48M$8.10M1.91%+$6.62M
Eupraxia Pharmaceuticals Inc.(EPRX)1,200,0001,200,0000$8.69M$7.93M1.87%-$756.0K
Bright Minds Biosciences Inc.(DRUG)220,000109,603-110,397$16.05M$7.69M1.81%-$8.36M
InflaRx N.V.(IFRX)03,046,557+3,046,557$0$6.82M1.61%+$6.82M
Relmada Therapeutics, Inc.(RLMD)842,106842,1060$5.86M$5.83M1.37%-$33.7K
Jatt Ii Acquisition Corp0500,000+500,000$0$5.68M1.34%+$5.68M
Cullinan Therapeutics, Inc.(CGEM)300,000300,0000$4.26M$5.46M1.29%+$1.20M
Altimmune, Inc.(ALT)01,741,232+1,741,232$0$5.29M1.25%+$5.29M
Amanat Acquisition CorpCL A0500,000+500,000$0$5.08M1.20%+$5.08M
Rezolute, Inc.(RZLT)951,809951,8090$2.90M$4.95M1.17%+$2.05M
Silence Therapeutics plcADS(SLN)1,020,489450,000-570,489$5.38M$4.94M1.16%-$437.0K
Palisade Bio, Inc.(PALI)3,405,7572,284,819-1,120,938$5.96M$4.78M1.13%-$1.18M
Evommune, Inc.(EVMN)325,000325,0000$7.47M$4.32M1.02%-$3.15M
Scynexis Inc0944,292+944,292$0$3.84M0.91%+$3.84M
Enliven Therapeutics Inc070,000+70,000$0$3.55M0.84%+$3.55M
Humacyte, Inc.(HUMA)3,750,0003,750,0000$2.28M$2.93M0.69%+$651.4K
Rein Therapeutics Inc.(RNTX)02,575,000+2,575,000$0$2.68M0.63%+$2.68M
DBV Technologies S.A.ADS(DBVT)0156,906+156,906$0$2.57M0.61%+$2.57M
ProMIS Neurosciences, Inc.(PMN)371,40286,150-285,252$4.72M$1.13M0.27%-$3.58M
Alkermes plcSHS(ALKS)50,0000-50,000$1.77M$0—-$1.77M
Apogee Therapeutics Inc374,0000-374,000$31.48M$0—-$31.48M
Avalo Therapeutics, Inc.(AVTX)124,6660-124,666$1.86M$0—-$1.86M
Compass Therapeutics, Inc.(CMPX)1,350,0000-1,350,000$7.14M$0—-$7.14M
Context Therapeutics Inc.(CNTX)2,238,4960-2,238,496$5.86M$0—-$5.86M
Immunovant, Inc.(IMVT)545,6250-545,625$13.55M$0—-$13.55M
Jade Biosciences Inc964,4620-964,462$13.55M$0—-$13.55M
Kalvista Pharmaceuticals Inc675,0000-675,000$13.59M$0—-$13.59M
Pharvaris N V
COM
82,8000-82,800$2.34M$0—-$2.34M
SCYNEXIS, Inc.(SCYX)7,554,3470-7,554,347$6.93M$0—-$6.93M
Tenax Therapeutics, Inc.(TENX)327,3070-327,307$5.23M$0—-$5.23M
Unicycive Therapeutics, Inc.(UNCY)796,5580-796,558$5.24M$0—-$5.24M
Zenas BioPharma, Inc.(ZBIO)524,0660-524,066$10.25M$0—-$10.25M
Page 1 of 1
GREAT POINT PARTNERS LLC — 13F Holdings — Q2 2026 | TickerTrail